180 related articles for article (PubMed ID: 9101640)
1. Anticoagulant fucoidan fractions from Fucus vesiculosus induce platelet activation in vitro.
Dürig J; Bruhn T; Zurborn KH; Gutensohn K; Bruhn HD; Béress L
Thromb Res; 1997 Mar; 85(6):479-91. PubMed ID: 9101640
[TBL] [Abstract][Full Text] [Related]
2. Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets.
Bachelet L; Bertholon I; Lavigne D; Vassy R; Jandrot-Perrus M; Chaubet F; Letourneur D
Biochim Biophys Acta; 2009 Feb; 1790(2):141-6. PubMed ID: 19026722
[TBL] [Abstract][Full Text] [Related]
3. Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysis.
Maddineni J; Jeske WP; Baltasar F; Cornelli U; Manoni M; Hoppensteadt DA; Fareed J
Clin Appl Thromb Hemost; 2006 Jul; 12(3):311-7. PubMed ID: 16959684
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical and Biological Characterization of Fucoidan from Fucus vesiculosus Purified by Dye Affinity Chromatography.
Zayed A; Muffler K; Hahn T; Rupp S; Finkelmeier D; Burger-Kentischer A; Ulber R
Mar Drugs; 2016 Apr; 14(4):. PubMed ID: 27092514
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of the pro- and anticoagulant effects of Fucus vesiculosus fucoidan.
Zhang Z; Till S; Jiang C; Knappe S; Reutterer S; Scheiflinger F; Szabo CM; Dockal M
Thromb Haemost; 2014 Mar; 111(3):429-37. PubMed ID: 24285223
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects.
Taylor ML; Misso NL; Stewart GA; Thompson PJ
Clin Exp Allergy; 1996 Feb; 26(2):202-15. PubMed ID: 8835129
[TBL] [Abstract][Full Text] [Related]
7. Isolation and partial characterization of a novel amino sugar-containing fucan sulfate from commercial Fucus vesiculosus fucoidan.
Nishino T; Nishioka C; Ura H; Nagumo T
Carbohydr Res; 1994 Mar; 255():213-24. PubMed ID: 8181008
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of antithrombotic and antiplatelet activities of different fucoidans from Laminaria japonica.
Zhao X; Dong S; Wang J; Li F; Chen A; Li B
Thromb Res; 2012 Jun; 129(6):771-8. PubMed ID: 21872298
[TBL] [Abstract][Full Text] [Related]
9. Fixation with formaldehyde induces expression of activation dependent platelet membrane glycoproteins, P selectin (CD62) and GP53 (CD63).
Cahill MR; Macey MG; Newland AC
Br J Haematol; 1993 Jul; 84(3):527-9. PubMed ID: 7692932
[TBL] [Abstract][Full Text] [Related]
10. Fucoidan is the active component of fucus vesiculosus that promotes contraction of fibroblast-populated collagen gels.
Fujimura T; Shibuya Y; Moriwaki S; Tsukahara K; Kitahara T; Sano T; Nishizawa Y; Takema Y
Biol Pharm Bull; 2000 Oct; 23(10):1180-4. PubMed ID: 11041247
[TBL] [Abstract][Full Text] [Related]
11. Heparinoids algal and their anticoagulant, hemorrhagic activities and platelet aggregation.
de Azevedo TC; Bezerra ME; Santos Mda G; Souza LA; Marques CT; Benevides NM; Leite EL
Biomed Pharmacother; 2009 Aug; 63(7):477-83. PubMed ID: 19006655
[TBL] [Abstract][Full Text] [Related]
12. Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant.
Mody M; Lazarus AH; Semple JW; Freedman J
Transfus Med; 1999 Jun; 9(2):147-54. PubMed ID: 10354385
[TBL] [Abstract][Full Text] [Related]
13. Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor.
Huhle G; Abletshauser C; Mayer N; Weidinger G; Harenberg J; Heene DL
Thromb Res; 1999 Sep; 95(5):229-34. PubMed ID: 10515287
[TBL] [Abstract][Full Text] [Related]
14. Fucoidan is a novel platelet agonist for the C-type lectin-like receptor 2 (CLEC-2).
Manne BK; Getz TM; Hughes CE; Alshehri O; Dangelmaier C; Naik UP; Watson SP; Kunapuli SP
J Biol Chem; 2013 Mar; 288(11):7717-7726. PubMed ID: 23341451
[TBL] [Abstract][Full Text] [Related]
15. Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study.
Konijnenberg A; van der Post JA; Mol BW; Schaap MC; Lazarov R; Bleker OP; Boer K; Sturk A
Am J Obstet Gynecol; 1997 Aug; 177(2):434-42. PubMed ID: 9290465
[TBL] [Abstract][Full Text] [Related]
16. Fucoidan Inhibition of Osteosarcoma Cells Is Species and Molecular Weight Dependent.
Gupta D; Silva M; Radziun K; Martinez DC; Hill CJ; Marshall J; Hearnden V; Puertas-Mejia MA; Reilly GC
Mar Drugs; 2020 Feb; 18(2):. PubMed ID: 32046368
[TBL] [Abstract][Full Text] [Related]
17. Enhanced platelet aggregation and activation under conditions of hypothermia.
Xavier RG; White AE; Fox SC; Wilcox RG; Heptinstall S
Thromb Haemost; 2007 Dec; 98(6):1266-75. PubMed ID: 18064324
[TBL] [Abstract][Full Text] [Related]
18. Fucoidan from Fucus vesiculosus Fails to Improve Outcomes Following Intracerebral Hemorrhage in Mice.
Burchell SR; Iniaghe LO; Zhang JH; Tang J
Acta Neurochir Suppl; 2016; 121():191-8. PubMed ID: 26463947
[TBL] [Abstract][Full Text] [Related]
19. Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies.
Hagberg IA; Lyberg T
Platelets; 2000 May; 11(3):137-50. PubMed ID: 10938890
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease.
Murakami T; Komiyama Y; Masuda M; Kido H; Nomura S; Fukuhara S; Karakawa M; Iwasaka T; Takahashi H
Eur J Clin Invest; 1996 Nov; 26(11):996-1003. PubMed ID: 8957206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]